Legal & General Group PLC Rocket Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 72,908 shares of RCKT stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,908

Previous 66,197 10.14%

Holding current value

$1.35 Million

Previous $1.78 Million 12.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $138,649 - $179,317	6,711 Added 10.14%	72,908 $1.57 Million
Q1 2024 May 14, 2024	SELL	$26.16 - $30.74 $6,356 - $7,469	-243 Reduced 0.37%	66,197 $1.78 Million
Q4 2023 Feb 15, 2024	BUY	$16.78 - $31.94 $155,768 - $296,499	9,283 Added 16.24%	66,440 $1.99 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $40,975 - $65,391	2,719 Added 4.99%	57,157 $1.17 Million
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $10,036 - $14,278	605 Added 1.12%	54,438 $1.08 Million
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $205,917 - $294,726	13,041 Added 31.97%	53,833 $922,000
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $80,863 - $118,738	5,217 Added 14.66%	40,792 $798,000
Q3 2022 Nov 14, 2022	SELL	$12.37 - $18.41 $42,033 - $62,557	-3,398 Reduced 8.72%	35,575 $568,000
Q2 2022 Aug 22, 2022	BUY	$7.96 - $16.64 $73,821 - $154,319	9,274 Added 31.23%	38,973 $536,000
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $908 - $1,633	-69 Reduced 0.23%	29,699 $471,000
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $1,872 - $3,133	87 Added 0.29%	29,768 $650,000
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $207,459 - $370,507	7,566 Added 34.21%	29,681 $887,000
Q2 2021 Aug 12, 2021	BUY	$39.41 - $47.25 $14,699 - $17,624	373 Added 1.72%	22,115 $980,000
Q1 2021 May 17, 2021	BUY	$43.34 - $65.91 $723,778 - $1.1 Million	16,700 Added 331.22%	21,742 $965,000
Q4 2020 Feb 12, 2021	BUY	$23.3 - $59.57 $4,613 - $11,794	198 Added 4.09%	5,042 $277,000
Q3 2020 Nov 13, 2020	SELL	$20.5 - $28.59 $30,934 - $43,142	-1,509 Reduced 23.75%	4,844 $111,000
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $7,272 - $12,345	546 Added 9.4%	6,353 $133,000
Q1 2020 May 14, 2020	SELL	$9.71 - $25.11 $10,923 - $28,248	-1,125 Reduced 16.23%	5,807 $81,000
Q4 2019 Feb 13, 2020	BUY	$11.07 - $24.23 $13,737 - $30,069	1,241 Added 21.81%	6,932 $158,000
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $13,710 - $18,106	914 Added 19.13%	5,691 $85,000
Q1 2019 May 15, 2019	BUY	$13.45 - $19.01 $11,741 - $16,595	873 Added 22.36%	4,777 $84,000
Q4 2018 Feb 15, 2019	BUY	$11.21 - $23.53 $8,284 - $17,388	739 Added 23.35%	3,904 $58,000
Q2 2018 Aug 10, 2018	BUY	$14.58 - $23.0 $46,145 - $72,795	3,165 New	3,165 $62,000

Others Institutions Holding RCKT

# of Institutions

194

Shares Held

91.9M

Call Options Held

222K

Put Options Held

111K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.4B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Rocket Pharmaceuticals, Inc. Transaction History